Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model.

Journal of gastroenterology and hepatology - 1 Dec 2012

Zhang Zheng, Pan Qin, Duan Xiao-Yan, Liu Qiang, Mo Guo-Yu, Rao Gui-Rong, Fan Jian-Gao

Abstract excerpt

BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) overlapping with chronic hepatitis B virus (HBV) infection is undergoing a rapid increase in China. Therefore, the establishment and character of an animal model with both NAFLD and chronic HBV infection has become an urgent task. METH...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Viral
Share to Fatty Liver
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B virus

Share to Mice, Inbred BALB C

Share to Mice, Transgenic

Share to Non-alcoholic Fatty Liver Disease

Share to Virus Replication

Source

Identifiers

PMID: 22989301
DOI: 10.1111/j.1440-1746.2012.07268.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22989301-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fatty liver reduces hepatitis B virus replication in a genotype B hepatitis B virus transgenic mice model.PMID 22989301Read ↗

Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances.Semantic proximity Read ↗

Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.Semantic proximity Read ↗

Genetically modified mouse models for the study of nonalcoholic fatty liver diseaseSemantic proximity Read ↗

A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humans.Semantic proximity Read ↗

The expanding role of fish models in understanding non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Experimental models of non-alcoholic fatty liver disease in rats.Semantic proximity Read ↗

Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerioSemantic proximity Read ↗

Establishment of Novel Mouse Model of Dietary NASH Rapidly Progressing Into Liver Cirrhosis and TumorsSemantic proximity Read ↗

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.Semantic proximity Read ↗

Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR‐122Semantic proximity Read ↗

Salidroside Alleviates Lipid Metabolism Disorder and Inflammatory Response, and Promotes Hepatocyte Proliferation in Fatty Liver-Hemorrhagic Syndrome of Laying HensSemantic proximity Read ↗

Development of an Animal Model for Alcoholic Liver Disease in ZebrafishSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.